EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 5-May-2025 14:09 ET (5-May-2025 18:09 GMT/UTC)

AACR announces Fellows of the AACR Academy Class of 2025 and new AACR Academy President

American Association for Cancer Research
Grant and Award Announcement

The American Association for Cancer Research (AACR) today announced its newly elected 2025 class of Fellows of the AACR Academy.

Meeting: AACR Annual Meeting 2025

Platelet-rich plasma may support ovarian function in women with poor ovarian response

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — March 10, 2025 — A new research paper was published in Aging (Aging-US) on February 18, 2025, Volume 17, Issue 2, titled “Transcriptomic landscape of cumulus cells from patients <38 years old with a history of poor ovarian response (POR) treated with platelet-rich plasma (PRP).”

Journal: Aging-US

Studying chemical exposure and brain cancer risk in firefighters

Yale University
Peer-Reviewed Publication

A new study uncovered an association between exposure to chemicals commonly used in firefighting and glioma risk, reinforcing earlier research that has suggested a link between firefighting and the development of cancers.

The small study led by Dr. Elizabeth B. Claus, a professor at the Yale School of Public Health, member of Yale Cancer Center, and founder of the International Low Grade Glioma Registry, showed that the glioma tumors of some firefighters had a distinctive genetic pattern or “mutational signature.” Those specific signatures were previously shown to be caused by exposure to chemicals called haloalkanes, which are associated with flame retardants, fire extinguishants, and propellants. The study results were published March 10 in Cancer, a peer-reviewed journal of the American Cancer Society.

Journal: Cancer

Cryo-electron microscopy reveals hidden mechanics of DNA replication, sheds new light on cancer target

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

MSK researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a potential therapeutic target in cancer.

Journal: Science
Funder: NIH/National Institutes of Health, NIH/National Cancer Institute

X-ray snapshot: How light bends an active substance

Goethe University Frankfurt
Peer-Reviewed Publication

With the help of the world's most powerful X-ray laser, European XFEL, a research team led by Goethe University Frankfurt and the research centre DESY has achieved an important breakthrough: Using the example of the pharmaceutically active substance 2-thiouracil, they applied a long-established imaging technique to complex molecules for the first time. Although 2-thiouracil is no longer applied therapeutically, it is part of a group of chemically similar active substances that are used today as immunosuppressants or cytostatics. The study shows how UV radiation deforms 2-thiouracil, making it dangerously reactive.

Journal: Nature Communications

Study introduces online tool to guide surgical decisions for gallbladder cancer

Boston University School of Medicine
Peer-Reviewed Publication

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine have discovered key risk factors that can help predict when surgery for gallbladder cancer may not be beneficial, leading to ER or complications.

Journal: Annals of Surgical Oncology

Stand up to cancer adds new expertise to scientific advisory committee

Stand Up To Cancer
Business Announcement

Stand Up To Cancer has added new expertise to our Scientific Advisory Committee, which oversees SU2C’s scientific research in collaboration with our President and CEO, Julian Adams, Ph.D. With expertise in the areas of pediatric oncology, biostatistics and healthcare economics, our three newest members will be critical partners as we invest in bold science with the goal of reducing cancer deaths.

Prevalence of neutralizing antibodies to AAV2 and AAV9 in individuals with Niemann-Pick disease

Mary Ann Liebert, Inc./Genetic Engineering News
Peer-Reviewed Publication

A new study in the peer-reviewed journal Human Gene Therapy showed that more than half of individuals with Niemann-Pick disease, type C1 (NPC1) who were tested lacked neutralizing antibodies against either adeno-associated virus (AAV) 2 or AAV9.

Journal: Human Gene Therapy

Reprogramming immune cells to improve cancer treatment

Vlaams Instituut voor Biotechnologie
Peer-Reviewed Publication

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center for Cancer Biology and their collaborators demonstrated a remarkable ability to boost the immune system's fight against cancer, showing promise for improving patient outcomes in difficult-to-treat malignancies. Their work appears in Nature Metabolism.

Journal: Nature Metabolism
Funder: FWO, Stichting Tegen Kanker, NIH, ERC

Shimadzu Corporation and DxD Hub establish joint lab to advance diagnostics innovation and improve healthcare outcomes

Agency for Science, Technology and Research (A*STAR), Singapore
Business Announcement

Shimadzu Corporation, a global leader in the precision instrumentation industry, and Diagnostics Development Hub (DxD Hub), a national platform hosted by Singapore’s Agency for Science, Technology and Research (A*STAR), are pleased to announce a strategic collaboration to establish the Shimadzu – DxD Hub Diagnomics Centre (SDDC) at Biopolis, Singapore. Officially launched today, the SDDC will drive innovation and accelerate the development of diagnostic products by integrating Shimadzu’s technological expertise with DxD Hub’s productisation platforms.

66
67
68
69
70